Grants per year
Personal profile
Research Interests
My clinical interests include primary brain and spinal cord tumors, metastatic tumors, and neurologic complications from cancer and its associated treatment. I have a special interest in central nervous system lymphoma and neuro-cutaneous disorders.
Training Experience
| 2012 | Internship, University of Illinois at Chicago |
| 2015 | Residency, University of Illinois at Chicago |
| 2016 | Fellowship, Northwestern University, McGaw Medical Center |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MD, Medicine, Louisiana State University
… → 2011
Research interests keywords
- Brain Cancer / Nervous System Cancer
- Neuro-Oncology
- Neurology
- Spinal Cord Tumors
Fingerprint
Dive into the research topics where Karan Singh Dixit is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 2 Finished
-
Prot# NU 15C03 - A Phase II, Open Label, Clinical Trial Of Pre-Surgical and Adjuvant Treatment of Recurrent Glioblastoma with Tremelimumab and Durvalumab (MEDI4736) Alone and in Combination To Determine Immunologic Changes From Treatment
Dixit, K. S. & Raizer, J. J.
AstraZeneca Pharmaceuticals LP
6/13/16 → 7/1/22
Project: Research project
-
Prot #NU 15C01: Phase I/II trial of Radiation Therapy plus Temozolomide with MK-3475 in patients with newly diagnosed Glioblastoma (GBM)
Dixit, K. S., Raizer, J. J. & Raizer, J. J.
Merck Sharp & Dohme Corporation
9/15/15 → 9/15/22
Project: Research project
-
A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics
Kumthekar, P. U., Avram, M. J., Lassman, A. B., Lin, N. U., Lee, E., Grimm, S. A., Schwartz, M., Bell Burdett, K. L., Lukas, R. V., Dixit, K., Perron, I., Zhang, H., Gradishar, W. J., Pentsova, E. I., Jeyapalan, S., Groves, M. D., Melisko, M. & Raizer, J. J., Mar 14 2023, In: Neuro-oncology. 25, 3, p. 557-565 9 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial
Sonabend, A. M., Gould, A., Amidei, C., Ward, R., Schmidt, K. A., Zhang, D. Y., Gomez, C., Bebawy, J. F., Liu, B. P., Bouchoux, G., Desseaux, C., Helenowski, I. B., Lukas, R. V., Dixit, K., Kumthekar, P., Arrieta, V. A., Lesniak, M. S., Carpentier, A., Zhang, H., Muzzio, M., & 2 others, May 2023, In: The Lancet Oncology. 24, 5, p. 509-522 14 p.Research output: Contribution to journal › Article › peer-review
-
Clinical Problem-Solving: Lower Extremity Weakness & Paresthesia in an Immunocompromised Patient With a Complex Cancer History
Stamm, B., Yu, M., Adrissi, J., Brooker, S. M., Hac, N. E. F., Priyadarshini, S. & Dixit, K., Jan 2022, In: Neurohospitalist. 12, 1, p. 183-187 5 p.Research output: Contribution to journal › Article › peer-review
-
Common symptoms at presentation of nervous system metastases
Cao, T., Rosenberg, A., Kumthekar, P. & Dixit, K. S., Jan 1 2022, Neurological Complications of Systemic Cancer and Antineoplastic Therapy. Elsevier, p. 3-8 6 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
Sarcoma and the nervous system
Dixit, K. S., Wolinsky, J-P., Kumthekar, P., Horbinski, C. & Lukas, R. V., Jan 1 2022, Neurological Complications of Systemic Cancer and Antineoplastic Therapy. Elsevier, p. 401-413 13 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter